1031 related articles for article (PubMed ID: 29428311)
1. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
2. Impact of tamoxifen therapy on fertility in breast cancer survivors.
Shandley LM; Spencer JB; Fothergill A; Mertens AC; Manatunga A; Paplomata E; Howards PP
Fertil Steril; 2017 Jan; 107(1):243-252.e5. PubMed ID: 27887709
[TBL] [Abstract][Full Text] [Related]
3. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study.
Ahmad AK; Kao CN; Quinn M; Lenhart N; Rosen M; Cedars MI; Huddleston H
Fertil Steril; 2018 Mar; 109(3):526-531. PubMed ID: 29428308
[TBL] [Abstract][Full Text] [Related]
4. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation in childhood and adolescent female tumor survivors.
Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of ovarian reserve in women with polycystic ovary syndrome.
Huddleston HG
Semin Reprod Med; 2013 Nov; 31(6):452-61. PubMed ID: 24101226
[TBL] [Abstract][Full Text] [Related]
7. Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.
Greenwood EA; Cedars MI; Santoro N; Eisenberg E; Kao CN; Haisenleder DJ; Diamond MP; Huddleston HG;
Fertil Steril; 2017 Dec; 108(6):1070-1077. PubMed ID: 29202959
[TBL] [Abstract][Full Text] [Related]
8. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
10. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
[TBL] [Abstract][Full Text] [Related]
11. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
[TBL] [Abstract][Full Text] [Related]
12. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
[TBL] [Abstract][Full Text] [Related]
13. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
Weerakiet S; Lertvikool S; Tingthanatikul Y; Wansumrith S; Leelaphiwat S; Jultanmas R
Gynecol Endocrinol; 2007; 23(8):455-60. PubMed ID: 17852413
[TBL] [Abstract][Full Text] [Related]
14. A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders.
Vagios S; James KE; Sacha CR; Hsu JY; Dimitriadis I; Bormann CL; Souter I
Fertil Steril; 2021 Jan; 115(1):229-237. PubMed ID: 33077236
[TBL] [Abstract][Full Text] [Related]
15. Impact of cancer therapies on ovarian reserve.
Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
[TBL] [Abstract][Full Text] [Related]
16. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
Feldman RA; O'Neill K; Butts SF; Dokras A
Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
[TBL] [Abstract][Full Text] [Related]
17. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
18. A 10-year follow up of reproductive function in women treated for childhood cancer.
Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
20. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
